These conversions have to run their course first, don't you think? A "seasoned big pharma" CEO wouldn't sign on with intellicell in the state it is in now financially
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.